Current Oncology, Canada’s premier cancer research journal, proudly conceived and published by Multimed Inc. for over 27 years, is changing hands. Multimed has agreed to sell the Journal to MDPI, a multinational publishing firm, with the primary goal of sharing the impact of its’ scholarly research with a broad global audience. Please read our announcement for more information.

Effective October 29, 2020, for all new submissions to Current Oncology, authors will be re-directed to upload their manuscript to MDPI’s submission platform.

To start a new submission, please visit:

Kindly note that you will be requested to register and create a new username and password with the new publisher’s site, and complete your profile. If you require technical support, please contact

New journal website: 

For articles submitted prior to October 29, 2020, your articles will continue to be processed through our existing Open Journal Systems platform, and you can access your manuscript through our Current Oncology website with your existing login. Multimed is currently in the process of transitioning all in-progress manuscripts that are being considered for publication to MDPI. Once the submission files are transferred, the MDPI team will be in communication with you on how to access and track your submission through their system.

If you have any questions, please contact Multimed’s publishing team at